Copyright: ©Author(s) 2026.
World J Hepatol. May 27, 2026; 18(5): 119798
Published online May 27, 2026. doi: 10.4254/wjh.v18.i5.119798
Published online May 27, 2026. doi: 10.4254/wjh.v18.i5.119798
Table 1 Baseline characteristics of the training and validation datasets, n (%)/median (interquartile range)
| Variables | Training set (n = 768) | Validation set (n = 330) | P values |
| Gender (male/female) | Male 473 (61.6) | Male 211 (63.9) | 0.50 |
| Female 295 (38.4%) | Female 119 (36.1%) | ||
| Age (years) | 36.00 (30.00, 44.25) | 37.00 (30.25, 45.75) | 0.56 |
| Weight (kg) | 61.00 (53.00, 69.00) | 61.80 (54.00, 69.00) | 0.85 |
| Height (cm) | 167.00 (160.00, 171.00) | 168.00 (160.00, 173.00) | 0.27 |
| Hepatitis B virus DNA (log10 IU/mL) | 5.90 (3.78, 7.63) | 6.14 (3.56, 7.62) | 0.59 |
| Hepatitis B surface antigen (log10 IU/mL) | 3.59 (3.07, 4.22) | 3.57 (3.04, 4.32) | 0.76 |
| Hepatitis B surface antibody (mIU/mL) | 0.19 (0.00, 1.10) | 0.10 (0.00, 1.00) | 0.21 |
| Hepatitis B e antigen (COI) | 0.59 (0.11, 700.00) | 0.50 (0.17, 700.00) | 0.86 |
| Hepatitis B e antibody (COI) | 0.32 (0.01, 13.39) | 0.22 (0.01, 7.99) | 0.26 |
| Hepatitis B core antibody (COI) | 7.95 (0.01, 9.27) | 7.66 (0.01, 9.35) | 0.71 |
| White blood cell (109/L) | 5.30 (4.50, 6.20) | 5.30 (4.40, 6.10) | 0.84 |
| Neutrophil Abs. count (109/L) | 2.90 (2.40, 3.60) | 3.00 (2.40, 3.70) | 0.45 |
| Hemoglobin (g/L) | 145.00 (132.00, 155.25) | 146.00 (132.25, 156.00) | 0.67 |
| Platelet (109/L) | 202.00 (168.00, 239.00) | 195.00 (165.00, 229.00) | 0.02 |
| Prothrombin time (seconds) | 13.10 (12.62, 13.70) | 13.10 (12.60, 13.70) | 0.91 |
| International normalized ratio | 1.01 (0.97, 1.06) | 1.02 (0.97, 1.06) | 0.62 |
| Albumin (g/L) | 44.00 (42.00, 46.00) | 44.00 (42.00, 46.00) | 0.52 |
| Globulin (g/L) | 31.00 (28.00, 34.00) | 30.00 (27.00, 34.00) | 0.62 |
| Total bilirubin (μmol/L) | 16.05 (11.80, 21.50) | 15.50 (12.10, 21.10) | 0.88 |
| Direct bilirubin (μmol/L) | 4.85 (3.00, 7.20) | 4.80 (2.90, 7.47) | 0.92 |
| Alanine aminotransferase (U/L) | 68.00 (44.00, 116.00) | 68.00 (47.00, 118.00) | 0.65 |
| Aspartate aminotransferase (U/L) | 49.00 (27.75, 94.00) | 44.00 (25.00, 89.75) | 0.17 |
| Gamma-glutamyl transferase (U/L) | 33.00 (21.00, 62.00) | 31.50 (21.00, 56.00) | 0.44 |
| Alkaline phosphatase (U/L) | 63.00 (33.00, 83.00) | 61.00 (31.25, 81.00) | 0.64 |
| Alpha-fetoprotein (ng/mL) | 2.95 (1.75, 5.55) | 2.79 (1.82, 4.64) | 0.51 |
| Liver stiffness measurement (kPa) | 7.40 (5.60, 10.60) | 7.30 (5.50, 10.20) | 0.70 |
- Citation: Lin JY, Ai ZX, Luo MJ, Su LZ, Gao XG, Jiang HL, Lin JQ, Zhang HY, Sun YY, Yu HT, Zhang L, Gong XQ. Liver stiffness-platelet ratio index and machine learning models for the noninvasive diagnosis of significant fibrosis in chronic hepatitis B. World J Hepatol 2026; 18(5): 119798
- URL: https://www.wjgnet.com/1948-5182/full/v18/i5/119798.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i5.119798